PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsFluoride ion
Fluoride
Dibasic, Monobasic, Monohydrate, Phosphate (fluoride) is a small molecule pharmaceutical. Fluoride was first approved as Sodium phosphates in plastic container on 1983-05-10.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sodium fluoride
+
Triclosan
Tradename
Company
Number
Date
Products
COLGATE TOTALColgate-PalmoliveN-020231 DISCN1997-07-11
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
2080 k ginger mintOTC monograph final2017-01-10
2080 k herbal mintOTC monograph final2017-01-10
2080 k originalOTC monograph final2017-04-26
365 whole foods market anticavity/antigingivitis mouthwashOTC monograph not final2022-05-12
3seconds magic gargle lemonOTC monograph final2020-02-09
3seconds magic gargle peachOTC monograph final2020-02-10
4 packC2002632023-12-21
60 second fluoride gelunapproved drug other2022-01-24
60 second gel bubblegum 60 second gel grape 60 second gel mint 60 second gel orange cream 60 second gel strawberryunapproved drug other2017-02-14
60 second taste bubblegumunapproved drug other2022-12-19
Show 1069 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infections and mycoses—D001423—
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Sodium Phosphate, Dibasic, Anhydrous / Sodium Phosphate, Monobasic, Monohydrate, Osmoprep, Salix Pharms
76870752028-06-22DS, DP
ATC Codes
A: Alimentary tract and metabolism drugs
— A01: Stomatological preparations
— A01A: Stomatological preparations
— A01AA: Caries prophylactic agents
— A01AA01: Sodium fluoride
— A01AA04: Stannous fluoride
— A01AA51: Sodium fluoride, combinations
— A12: Mineral supplements
— A12C: Other mineral supplements in atc
— A12CD: Fluoride supplements
— A12CD01: Sodium fluoride
— A12CD51: Fluoride, combinations
V: Various drug classes in atc
— V09: Diagnostic radiopharmaceuticals
— V09I: Tumour detection radiopharmaceuticals
— V09IX: Other diagnostic radiopharmaceuticals for tumour detection in atc
— V09IX06: Sodium fluoride (18f)
HCPCS
Code
Description
A9580
["Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries"]
Q9950
["Injection, sulfur hexafluoride lipid microspheres, per ml"]
Clinical
Clinical Trials
1066 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dental plaqueD003773———2203126
GingivitisD005891—K05.10—2138326
Dental cariesD003731EFO_0003819K021351—10
Periodontal diseasesD010510—K05.6——6219
HypersensitivityD006967EFO_0003785T78.40——6118
Dentin sensitivityD003807————41—5
InflammationD007249MP_0001845————224
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gingival diseasesD005882—K05.1——10——10
Gingival hemorrhageD005884————2—13
PeriodontitisD010518EFO_0000649K05.3——2——2
MucositisD052016EFO_1001898———1——1
Cardiovascular diseasesD002318EFO_0000319I98——1——1
Bacterial infectionsD001424—A49——1——1
Tooth lossD016388————1——1
Tooth erosionD014077—K03.2——1——1
Tooth discolorationD014075—K03.6——1——1
Tooth demineralizationD017001————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronavirus infectionsD018352EFO_0007224B34.2—1——12
Covid-19D000086382—U07.1—1———1
InfectionsD007239EFO_0000544——1———1
Communicable diseasesD003141———1———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E11————11
HemorrhageD006470MP_0001914R58————11
Autism spectrum disorderD000067877—F84.0————11
Movement disordersD009069EFO_0004280G25————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFluoride
INNpegamotecan
Description
Fluorine F-18, Sodium Fluoride F 18 (fluoride) is a small molecule pharmaceutical. Fluoride was first approved as Fluorine F-18 on 1982-01-01.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
F
Identifiers
PDB—
CAS-ID7664-39-3
RxCUI—
ChEMBL IDCHEMBL1232767
ChEBI ID29228
PubChem CID28179
DrugBank—
UNII IDZY7ZTE7LFH (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Fluoride
+
Fluoride ion
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 179,510 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
6,128 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use